You are here: Home / Resources / Teaching Materials / A discussion of C-Path, regulation science, and recommended drug treatments with Nicholas King / Description
Resource Image

A discussion of C-Path, regulation science, and recommended drug treatments with Nicholas King

Author(s): Nicholas King1, Megan Seifert2

1. Critical Path Institute’s Biomarker Program 2. Headwaters Science Institute

590 total view(s), 95 download(s)

0 comment(s) (Post a comment)

Download

Adapt 0
Summary:
Nicholas King acts as the Scientific Program Manager for the Critical Path (C-Path) Institute’s Biomarker Program. He discusses the journey he has been on to arrive at his position, what the Critical Path Institute and consensus-based collaborative…

more

Nicholas King acts as the Scientific Program Manager for the Critical Path (C-Path) Institute’s Biomarker Program. He discusses the journey he has been on to arrive at his position, what the Critical Path Institute and consensus-based collaborative research are, and his experience working with health authorities.

Licensed under CC Attribution-NonCommercial-ShareAlike 4.0 International according to these terms

Version 1.0 - published on 15 Jun 2022 doi:10.25334/FAC6-GG40 - cite this

Keywords

  1. health
  2. Collaborative research
  3. drug discovery

Alignments

  1. Resource Type
  2. Audience Level
  3. Open Science and Education Practices Ontology
Contents:
view all files

Description

Please click here to take our Lunch with a Scientist QuestionPro survey.
 

Nicholas King graduated from the University of Arizona College of Medicine’s Cell Biology program with a Master’s degree in 2009. He is now the Scientific Program Manager for the Critical Path Institute’s Biomarker Program. He discusses the journey he has been on to arrive at his position, what the Critical Path Institute and consensus-based collaborative research are, and his experience working with health authorities.

Cite this work

Researchers should cite this work as follows:

Close

Home

Search